Insider Trading Volume Dropped In the Drug Industry

Even though insider buy ratio only declined slightly from 27% to 26%, number of net buyers decreased from 37 to 25 while number of net seller decreased from 99 to 73.
By: insiderslab.com
 
June 29, 2011 - PRLog -- According a Financial Time report, global drug industry cut its research spending for the first time in a decade and the pace of decline looks to quicken this year. Total R&D spending in the drug industry fell to a 3-year low of $68 billion, despite record sales in 2010 of $856 billion. Insider trading volume in the industry shrank in terms of number of net buyers and sellers. Even though insider buy ratio only declined slightly from 27% to 26%, number of net buyers decreased from 37 to 25 while number of net seller decreased from 99 to 73. For more data and analysis about insider trading, please visit http://www.insiderslab.com/media/mediaRoom.php

NeurogesX, Inc  Arkin Moshe, major shareholder of NeurogesX, sold 300,000 company shares at $3.20 on June 16. This transaction, which netted Arkin $961,380, significantly reduced his shareholding in the company by 57%. Breen Doron, another major shareholder, sold 399,002 shares at $3.14 on June 16 and lowered his shareholding in the company by 51%. The stock was trading at a 4-week high of $3.44 on June 16 and was closed at $1.98 on June 27. Read (NGSX) insider trading report at http://www.insiderslab.com/Notable/NGSX/

Warner Chilcott Plc   Cross Leland H, senior vice president of Warner Chilcott, sold 79,563 company shares at $22.29 on June 10. He also sold 100,000 shares at $22.41 on June 9. The executive cashed 4.01 million dollars in these 2 transactions and significantly reduced his shareholdings in the company by 59%. The stock touched a 4-week high of $24.37 on May 31 and was closed at $24.03 on June 27.  Read (WCRX) insider trading report at http://www.insiderslab.com/Notable/WCRX/

Medivation, Inc.  Qvt Associates Gp LLC, major shareholder of Medivation, sold 368,147 shares at $22.62 on June 7. It also sold 127,834 shares at $22.21 on June 6 and reduced his total shareholdings in the company by 13% in 2 business day. The stock reached a 4-week high of $24.41 and was closed at $21.84 on June 27. Read (MDVN) insider trading report at http://www.insiderslab.com/Notable/MDVN/


Contact the editor of this report Tim Fang in Vancouver at Tim@insiderslab.com

# # #

InsidersLab provides U.S. Insider Trading Research and Analysis to investors. We strive to aid investors, analysts, advisors and institutions in achieving optimal portfolio performance returns by providing more transparency in the insiders market.
End
Source:insiderslab.com
Email:***@insiderslab.com Email Verified
Tags:Medivation, Mdvn, Warner Chilcott, Wcrx, NGSX, NeurogesX, Insider Trading, Drug
Industry:Financial, Banking, Research
Location:Canada
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share